TRIAMCINOLONE: 6,691 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
6,691
Total FAERS Reports
369 (5.5%)
Deaths Reported
1,419
Hospitalizations
6,691
As Primary/Secondary Suspect
405
Life-Threatening
428
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available
FDA Application: 011161 ·
First Report: 196305 · Latest Report: 20250908
What Are the Most Common TRIAMCINOLONE Side Effects?
#1 Most Reported
Drug ineffective
3,035 reports (45.4%)
#2 Most Reported
Psoriasis
1,131 reports (16.9%)
#3 Most Reported
Off label use
901 reports (13.5%)
All TRIAMCINOLONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 3,035 | 45.4% | 159 | 555 |
| Psoriasis | 1,131 | 16.9% | 19 | 328 |
| Off label use | 901 | 13.5% | 116 | 458 |
| Product use in unapproved indication | 724 | 10.8% | 170 | 186 |
| Condition aggravated | 625 | 9.3% | 76 | 396 |
| Therapeutic product effect incomplete | 624 | 9.3% | 110 | 152 |
| Treatment failure | 612 | 9.2% | 151 | 101 |
| Drug intolerance | 527 | 7.9% | 166 | 373 |
| Nausea | 525 | 7.9% | 122 | 411 |
| Pruritus | 485 | 7.3% | 45 | 57 |
| Vomiting | 485 | 7.3% | 148 | 419 |
| Synovitis | 478 | 7.1% | 179 | 403 |
| Arthralgia | 461 | 6.9% | 144 | 134 |
| Adrenal insufficiency | 459 | 6.9% | 22 | 385 |
| Obesity | 455 | 6.8% | 129 | 373 |
| Rash | 452 | 6.8% | 139 | 131 |
| Diarrhoea | 442 | 6.6% | 108 | 375 |
| Pain | 418 | 6.3% | 121 | 231 |
| Dizziness | 408 | 6.1% | 137 | 305 |
| Contraindicated product administered | 376 | 5.6% | 176 | 256 |
Who Reports TRIAMCINOLONE Side Effects? Age & Gender Data
Gender: 62.8% female, 37.2% male. Average age: 47.4 years. Most reports from: US. View detailed demographics →
Is TRIAMCINOLONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 0 | 0 |
| 2003 | 7 | 0 | 5 |
| 2004 | 2 | 0 | 1 |
| 2005 | 9 | 0 | 5 |
| 2006 | 4 | 0 | 1 |
| 2007 | 2 | 1 | 0 |
| 2008 | 4 | 0 | 1 |
| 2009 | 3 | 0 | 0 |
| 2010 | 9 | 0 | 3 |
| 2011 | 3 | 0 | 1 |
| 2012 | 13 | 0 | 1 |
| 2013 | 17 | 1 | 7 |
| 2014 | 40 | 2 | 23 |
| 2015 | 48 | 0 | 14 |
| 2016 | 41 | 4 | 12 |
| 2017 | 54 | 0 | 24 |
| 2018 | 84 | 1 | 27 |
| 2019 | 91 | 3 | 29 |
| 2020 | 47 | 3 | 14 |
| 2021 | 58 | 1 | 16 |
| 2022 | 72 | 1 | 32 |
| 2023 | 142 | 4 | 22 |
| 2024 | 60 | 0 | 15 |
| 2025 | 23 | 0 | 7 |
What Is TRIAMCINOLONE Used For?
| Indication | Reports |
|---|---|
| Psoriasis | 1,886 |
| Product used for unknown indication | 1,376 |
| Juvenile idiopathic arthritis | 246 |
| Rheumatoid arthritis | 156 |
| Psoriatic arthropathy | 149 |
| Migraine | 116 |
| Eczema | 110 |
| Hidradenitis | 108 |
| Dermatitis atopic | 92 |
| Cystoid macular oedema | 83 |
TRIAMCINOLONE vs Alternatives: Which Is Safer?
TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE
TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE
TRIAMCINOLONE vs TRIAMTERENE
TRIAMCINOLONE vs TRIATEC
TRIAMCINOLONE vs TRIAZOLAM
TRIAMCINOLONE vs TRICHLORMETHIAZIDE
TRIAMCINOLONE vs TRICLOSAN
TRIAMCINOLONE vs TRIENTINE
TRIAMCINOLONE vs TRIENTINE TETRAHYDROCHLORIDE
TRIAMCINOLONE vs TRIFAROTENE
Official FDA Label for TRIAMCINOLONE
Official prescribing information from the FDA-approved drug label.